CClinicalTrials.gg
CompletedNCT01120704AdherenceUpdated Dec 11, 2015Results posted

Evaluation of Treatments to Improve Smoking Cessation Medication Adherence

A Phase 4 interventional study of Short Term Combination Nicotine Replacement Therapy (patch + gum) and Long Term Combination Nicotine Replacement Therapy (patch + gum) in Smoking, Smoking Cessation and Adherence, sponsored by University of Wisconsin, Madison. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2015-12-11.

Sponsored by University of Wisconsin, Madison · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
544
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Many smokers fail to take their smoking cessation medication as recommended. This research is designed to identify treatments that improve the use of cessation medications and to determine whether an increase in medication use results in increased cessation success. This research will also identify treatments that help people stay quit after a quit attempt and will pioneer more efficient research methods.

Read the detailed description

Nonadherent use of smoking cessation medications is very common and highly associated with cessation failure. However, little is presently known about how to improve adherence and whether improved adherence will actually boost cessation success (i.e., its causal role is unknown). This research represents groundbreaking integration of 1) basic theory and data on tobacco dependence, adherence, and intervention mechanisms with 2) the state-of-the-art Intervention Optimization Cycle methodology. This methodology uses factorial designs to efficiently engineer and evaluate intervention components, and to develop an optimal comprehensive treatment package. Participants in Project 3 will be smokers (N = 544) visiting primary care clinics for a regular outpatient visit who, when asked, express an interest in quitting and agree to participate in a smoking cessation research study. The experiment will comprise five experimental factors (2X2X2X2X2), and participants will have a 50% chance of being assigned one of the levels of each factor. The five factors include one medication factor (medication duration: 8 vs. 26 weeks), one counseling factor (maintenance counseling vs. no maintenance counseling), and three adherence factors: 1) Cognitive Medication Adherence Counseling (C-MAC); C-MAC vs. no C-MAC; 2) electronic medication monitoring device (the Helping Hand) + Feedback vs. the medication monitoring device alone; and 3) automated adherence prompting phone calls vs. no prompting.

02

Conditions studied

  • Smoking
  • Smoking Cessation
  • Adherence
  • Nicotine Dependence
  • Motivation

Browse trials for

Keywords

  • Smoking
  • Smoking Cessation
  • Adherence
  • Nicotine
  • Motivation
03

In context

Tobacco Use Disorder

968 studies on the registry are indexed under Tobacco Use Disorder; 126 are open to participants now.

This study's enrollment of 544 is above the median of 89 across 851 interventional studies indexed under Tobacco Use Disorder.

Browse Tobacco Use Disorder studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.

Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years of age or older;
  • Report smoking at least 5 cigarettes per day for the previous 6 months;
  • Able to read and write English;
  • Agree to attend visits, to respond to coaching calls, and to respond to Interactive Voice Response (IVR) phone prompts;
  • Plans to remain in the intervention catchment area for at least 12 months;
  • Currently interested in quitting smoking (defined as would like to try to quit in the next 30 days).
  • All women of childbearing potential will be required to agree to use an acceptable method of birth control to prevent pregnancy during the study.

Exclusion criteria

Exclusion Criteria:

  • Currently taking bupropion, Wellbutrin, chantix or varenicline (current use of NRT is not exclusionary if the participant agrees to use only study medication for the duration of the study);
  • Study candidate is pregnant, trying to get pregnant, or nursing.
  • A history of psychosis or bipolar disorder
  • A history of skin or allergic reactions while using a nicotine patch.
  • Had a heart attack, stroke, or abnormal electrocardiogram within the past 4 weeks.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
544 participants (actual)

Study arms

  • Experimental
    1, 26Wks, Counseling, CAM, AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, Maintenance Counseling, Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    2, 26Wks, Counseling, CAM, AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, Maintenance Counseling, Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    3, 26Wks, Counseling, CAM, No AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, Maintenance Counseling, Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback

  • Experimental
    4, 26Wks, Counseling, CAM, No AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, Maintenance Counseling, Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Cognitive Medication Adherence Counseling (CAM)

  • Experimental
    5, 26Wks, Counseling, No CAM, AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, Maintenance Counseling, No Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    6, 26Wks, Counseling, No CAM, AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, Maintenance Counseling, No Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    7, 26Wks, Counseling, No CAM, No AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, Maintenance Counseling, No Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback

  • Experimental
    8, 26Wks, Counseling, No CAM, No AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, Maintenance Counseling, No Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling

  • Experimental
    9, 26Wks, No Counseling, CAM, AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, No Maintenance Counseling, Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    10, 26Wks, No Counseling, CAM, AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, No Maintenance Counseling, Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    11, 26Wks, No Counseling, CAM, No AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, No Maintenance Counseling, Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback

  • Experimental
    12, 26Wks, No Counseling, CAM, No AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, No Maintenance Counseling, Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Cognitive Medication Adherence Counseling (CAM)

  • Experimental
    13, 26Wks, No Counseling, No CAM, AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, No Maintenance Counseling, No Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    14, 26Wks, No Counseling, No CAM, AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, No Maintenance Counseling, No Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    15, 26Wks, No Counseling, No CAM, No AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, No Maintenance Counseling, No Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback

  • Experimental
    16, 26Wks, No Counseling, No CAM, No AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 26Wks Medication duration during quit attempt, No Maintenance Counseling, No Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Long Term Combination Nicotine Replacement Therapy (patch + gum)

  • Experimental
    17, 8Wks, Counseling, CAM, AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, Maintenance Counseling, Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    18, 8Wks, Counseling, CAM, AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, Maintenance Counseling, Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    19, 8Wks, Counseling, CAM, No AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, Maintenance Counseling, Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback

  • Experimental
    20, 8Wks, Counseling, CAM, No AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, Maintenance Counseling, Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Cognitive Medication Adherence Counseling (CAM)

  • Experimental
    21, 8Wks, Counseling, No CAM, AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, Maintenance Counseling, No Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    22, 8Wks, Counseling, No CAM, AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, Maintenance Counseling, No Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    23, 8Wks, Counseling, No CAM, No AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, Maintenance Counseling, No Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback

  • Experimental
    24, 8Wks, Counseling, No CAM, No AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, Maintenance Counseling, No Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Intensive Maintenance Counseling

  • Experimental
    25, 8Wks, No Counseling, CAM, AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, No Maintenance Counseling, Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    26, 8Wks, No Counseling, CAM, AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, No Maintenance Counseling, Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    27, 8Wks, No Counseling, CAM, No AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, No Maintenance Counseling, Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Cognitive Medication Adherence Counseling (CAM) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback

  • Experimental
    28, 8Wks, No Counseling, CAM, No AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, No Maintenance Counseling, Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Cognitive Medication Adherence Counseling (CAM)

  • Experimental
    29, 8Wks, No Counseling, No CAM, AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, No Maintenance Counseling, No Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    30, 8Wks, No Counseling, No CAM, AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, No Maintenance Counseling, No Cognitive Adherence Intervention, Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Automated Adherence Prompting Phone Calls

  • Experimental
    31, 8Wks, No Counseling, No CAM, No AutoCalls, Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, No Maintenance Counseling, No Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device + Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum) · Behavioral: Electronic Medication Monitoring Device (the Helping Hand) + Feedback

  • Experimental
    32, 8Wks, No Counseling, No CAM, No AutoCalls, No Feedback

    This arm of the project will address the following question: How effective is the following intervention?: 8Wks Medication duration during quit attempt, No Maintenance Counseling, No Cognitive Adherence Intervention, No Automated Medication Adherence Calls, Electronic Medication Monitoring Device but No Feedback

    Drug: Short Term Combination Nicotine Replacement Therapy (patch + gum)

Interventions

  • DrugShort Term Combination Nicotine Replacement Therapy (patch + gum)

    IF participant smokes \>10 cigs/day AND is randomized to a 8 week condition: they will be asked to take one 21 mg patch/day for 4 weeks, THEN one 14 mg patch/day for 2 weeks, THEN one patch 7mg/day for 2 weeks.Participants will also be asked to use 4-mg gum every 1-2 hours (9 pieces maximum per day)for 6 weeks and decrease gum use over the 2 weeks prior to medication termination until down to one gum piece every 4-8 hours by the last week of treatment. IF participant smokes 5-10 cigs/day AND is randomized to the 8 week medication condition: they will be asked to take one 14 mg patch/day for 4 weeks, THEN one 7 mg patch/day for 4 weeks. Participants will also be asked to use 2-mg gum every 1-2 hours (9 pieces max per day)for 6 weeks and decrease gum use over the 2 weeks prior to medication termination until down to one gum piece every 4-8 hours by the last week of treatment.

  • DrugLong Term Combination Nicotine Replacement Therapy (patch + gum)

    IF the participant smokes \>10 cigs/day AND is randomized to a 26 week medication condition: they will be asked to take one 21 mg patch per day for 22 weeks, THEN one 14 mg patch per day for 2 weeks, THEN one patch 7 mg patch per day for 2 weeks. Participants will also be asked to use one piece of one 4-mg- gum every 1-2 hours (9 pieces maximum per day)for 24 weeks and decrease gum use over the 2 weeks prior to medication termination until they are down to one gum piece every 4-8 hours by the last week of treatment. IF the participant smokes 5-10 cigs/day AND is randomized to a 26 week medication condition: they will be asked to take one 14 mg patch per day for 22 weeks, THEN one patch 7 mg patch per day for 4 weeks. Participants will also be asked to use one piece of 2-mg gum every 1-2 hours (9 pieces maximum per day)for 24 weeks and decrease gum use over the 2 weeks prior to medication termination until they are down to one gum piece every 4-8 hours by the last week of treatment.

  • BehavioralIntensive Maintenance Counseling

    Participants randomized to this condition will receive eight 15-minute phone counseling sessions at Weeks 3, 4, 6, 8, 10, 14, 18 \& 22. The counseling will encourage continued practice of coping skills, and avoidance of danger situations. Another emphasis will be the continued provision of social support as a means of enhancing motivation. Participants who have relapsed will receive counseling aimed at motivating and planning renewed quit attempts. Other aims are enhancing motivation, especially competence self-appraisals, providing intratreatment support, and encouraging pleasurable activities.

  • BehavioralCognitive Medication Adherence Counseling (CAM)

    Participants randomized to this condition will be given a brief (10 minute) session of CAM treatment at both Visits 1 and 2. CAM will include information on NRT such as the following: NRT reduces withdrawal and urges; sustained use reduces the likelihood of relapse; willpower and medication make a good combination; NRT will help a lapsing smoker reachieve abstinence. The tailored counseling component of the CAM intervention is based on brief evaluation of the smoker's beliefs, concerns, and possible misconceptions about smoking cessation medications.

  • BehavioralElectronic Medication Monitoring Device (the Helping Hand) + Feedback

    If randomized to this condition, the case manager will give patients a computer-generated feedback sheet showing the patient's medication self-administration since the last visit. The case manager will provide problem-solving counseling regarding barriers to medication use. This problem-solving counseling intervention will be given in brief in-person sessions (three in-person sessions for those in the 8 week medication condition and five in-person sessions for those in the 26 week medication condition). Medication monitoring counseling will also occur via phone (two 10-minute sessions for those in the 8 week medication condition and four 10-minute sessions for those in the 26 week medication condition).

  • BehavioralAutomated Adherence Prompting Phone Calls

    Participants in this condition will receive fully automated prompts with messages designed to encourage participants to take their medication. Adherence prompting calls will occur two times in the first week of the quit attempt, and then once a week in weeks 2, 3, 4, 5, and 7. Those in the 26-Week medication condition who are assigned to the active adherence prompting calls intervention, will receive one prompting call a week during Weeks 11, 15, 19 \& 23.

06

What researchers measure

Primary outcomes

  1. Self-Reported 7-Day Point-Prevalence Abstinence

    Self-Reported 7-Day Point-Prevalence Abstinence is a dichotomous outcome with values of 0 and 1 where 0=smoking on one or more of the past 7 days at the assessment endpoint (52 weeks post-quit) and 1=no smoking on any of the past 7 days at the assessment endpoint (i.e., abstinent for the past 7 days); this outcome will be analyzed in a logistic regression analysis model. Note: This abstinence primary outcome replaces latency to relapse (now designated as a secondary outcome) because reviewers of the now-accepted manuscript (at the journal "Addiction") advised us to change the primary outcome to the current week 52 Self-Reported 7-Day Point-Prevalence Abstinence.

    Time frame: Assessed at 52 weeks after target quit day

Secondary outcomes

  1. Latency to Relapse

    Latency to Relapse during the first 12 months post-quit, with relapse defined as 7 consecutive days of smoking; this outcome will be analyzed in a Cox regression survival analysis model with non-relapsers coded as right-censored

    Time frame: Assessed during the first 12 months post-quit after target quit day

07

Results

Posted Feb 16, 2015

Participant flow

Participant flow — Overall Study
Milestone1, 26Wks, Counseling, CAM, AutoCalls, Feedback2, 26Wks, Counseling, CAM, AutoCalls, No Feedback3, 26Wks, Counseling, CAM, No AutoCalls, Feedback4, 26Wks, Counseling, CAM, No AutoCalls, No Feedback5, 26Wks, Counseling, No CAM, AutoCalls, Feedback6, 26Wks, Counseling, No CAM, AutoCalls, No Feedback7, 26Wks, Counseling, No CAM, No AutoCalls, Feedback8, 26Wks, Counseling, No CAM, No AutoCalls, No Feedback9, 26Wks, No Counseling, CAM, AutoCalls, Feedback10, 26Wks, No Counseling, CAM, AutoCalls, No Feedback11, 26Wks, No Counseling, CAM, No AutoCalls, Feedback12, 26Wks, No Counseling, CAM, No AutoCalls, No Feedback13, 26Wks, No Counseling, No CAM, AutoCalls, Feedback14, 26Wks, No Counseling, No CAM, AutoCalls, No Feedback15, 26Wks, No Counseling, No CAM, No AutoCalls, Feedback16, 26Wks, No Counseling, No CAM, No AutoCalls, No Feedback17, 8Wks, Counseling, CAM, AutoCalls, Feedback18, 8Wks, Counseling, CAM, AutoCalls, No Feedback19, 8Wks, Counseling, CAM, No AutoCalls, Feedback20, 8Wks, Counseling, CAM, No AutoCalls, No Feedback21, 8Wks, Counseling, No CAM, AutoCalls, Feedback22, 8Wks, Counseling, No CAM, AutoCalls, No Feedback23, 8Wks, Counseling, No CAM, No AutoCalls, Feedback24, 8Wks, Counseling, No CAM, No AutoCalls, No Feedback25, 8Wks, No Counseling, CAM, AutoCalls, Feedback26, 8Wks, No Counseling, CAM, AutoCalls, No Feedback27, 8Wks, No Counseling, CAM, No AutoCalls, Feedback28, 8Wks, No Counseling, CAM, No AutoCalls, No Feedback29, 8Wks, No Counseling, No CAM, AutoCalls, Feedback30, 8Wks, No Counseling, No CAM, AutoCalls, No Feedback31, 8Wks, No Counseling, No CAM, No AutoCalls, Feedback32, 8Wks, No Counseling, No CAM, No AutoCalls, No Feedback
Started1317141916191515222017161719181814161718171621161814181819151418
Completed1013131514181213191916141415171613161515141617131614151614121217
Not completed34142132311234121023304320325321

Outcome measures

SecondaryLatency to Relapse

Latency to Relapse during the first 12 months post-quit, with relapse defined as 7 consecutive days of smoking; this outcome will be analyzed in a Cox regression survival analysis model with non-relapsers coded as right-censored

Time frame:
Assessed during the first 12 months post-quit after target quit day
Reported as:
Number · participants
Latency to Relapse
participants8 Weeks of Nicotine Patch and Nicotine Gum26 Weeks of Nicotine Patch and Nicotine GumNo Maintenance CounselingMaintenance CounselingNo Cognitive Medication Adherence CounselingCognitive Medication Adherence CounselingElectronic Medication Monitoring Device Without FeedbackElectronic Medication Monitoring Device Plus FeedbackNo Automated Adherence Prompting Phone CallsAutomated Adherence Prompting Phone Calls
# Participants Who Relapsed (Smoking)227209228208214222225211218218
# Participants Who Did Not Relapse (Not Smoking)42665355594949595454
Statistical analysis
  • 8 Weeks of Nicotine Patch and Nicotine Gum vs 26 Weeks of Nicotine Patch and Nicotine Gum · Regression, Cox · p = .045 · Cox proportional hazard: .906 · 95% CI .822 to .998
  • No Maintenance Counseling vs Maintenance Counseling · Regression, Cox · p = .705 · Cox proportional hazard: .982 · 95% CI .892 to 1.081
  • No Cognitive Medication Adherence Counseling vs Cognitive Medication Adherence Counseling · Regression, Cox · p = .382 · Cox proportional hazard: 1.044 · 95% CI .948 to 1.149
  • Electronic Medication Monitoring Device Without Feedback vs Electronic Medication Monitoring Device Plus Feedback · Regression, Cox · p = .339 · Cox proportional hazard: .954 · 95% CI .867 to 1.050
  • No Automated Adherence Prompting Phone Calls vs Automated Adherence Prompting Phone Calls · Regression, Cox · p = .248 · Cox proportional hazard: .945 · 95% CI .858 to 1.040
PrimarySelf-Reported 7-Day Point-Prevalence Abstinence

Self-Reported 7-Day Point-Prevalence Abstinence is a dichotomous outcome with values of 0 and 1 where 0=smoking on one or more of the past 7 days at the assessment endpoint (52 weeks post-quit) and 1=no smoking on any of the past 7 days at the assessment endpoint (i.e., abstinent for the past 7 days); this outcome will be analyzed in a logistic regression analysis model. Note: This abstinence primary outcome replaces latency to relapse (now designated as a secondary outcome) because reviewers of the now-accepted manuscript (at the journal "Addiction") advised us to change the primary outcome to the current week 52 Self-Reported 7-Day Point-Prevalence Abstinence.

Time frame:
Assessed at 52 weeks after target quit day
Reported as:
Number · participants
Self-Reported 7-Day Point-Prevalence Abstinence
participants8 Weeks of Nicotine Patch and Nicotine Gum26 Weeks of Nicotine Patch and Nicotine GumNo Maintenance CounselingMaintenance CounselingNo Cognitive Medication Adherence CounselingCognitive Medication Adherence CounselingElectronic Medication Monitoring Device Without FeedbackElectronic Medication Monitoring Device Plus FeedbackNo Automated Adherence Prompting Phone CallsAutomated Adherence Prompting Phone Calls
# Participants Who Smoking197181202176184194186192198180
# Participants Who Are Abstinent72947987897786807690
Statistical analysis
  • 8 Weeks of Nicotine Patch and Nicotine Gum vs 26 Weeks of Nicotine Patch and Nicotine Gum · Regression, Logistic · p = .011 · Odds ratio (or): 1.402 · 95% CI 1.080 to 1.821
  • No Maintenance Counseling vs Maintenance Counseling · Regression, Logistic · p = .956 · Odds ratio (or): 1.008 · 95% CI .769 to 1.321
  • No Cognitive Medication Adherence Counseling vs Cognitive Medication Adherence Counseling · Regression, Logistic · p = .885 · Odds ratio (or): 1.018 · 95% CI .797 to 1.301
  • Electronic Medication Monitoring Device Without Feedback vs Electronic Medication Monitoring Device Plus Feedback · Regression, Logistic · p = .205 · Odds ratio (or): .852 · 95% CI .664 to 1.092
  • No Automated Adherence Prompting Phone Calls vs Automated Adherence Prompting Phone Calls · Regression, Logistic · p = .514 · Odds ratio (or): 1.090 · 95% CI .842 to 1.411

Adverse events

Collected over AEs were reported for 8 or 26 weeks (for the duration of time when the participant was on medication.). Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
26 Weeks of Nicotine Patch and Nicotine Gum—10/275 (3.6%)146/275 (53.1%)
8 Weeks of Nicotine Patch and Nicotine Gum—6/269 (2.2%)141/269 (52.4%)
Most frequent serious events
Most frequent serious events
Event26 Weeks of Nicotine Patch and Nicotine Gum8 Weeks of Nicotine Patch and Nicotine Gum
CardiovascularCardiac disorders4/2755/269
GastrointestinalGastrointestinal disorders2/2750/269
Death-unknown causeGeneral disorders1/2751/269
PulmonaryRespiratory, thoracic and mediastinal disorders1/2750/269
MusculoskeletalMusculoskeletal and connective tissue disorders1/2750/269
CancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)1/2750/269
Most frequent other events
Most frequent other events
Event26 Weeks of Nicotine Patch and Nicotine Gum8 Weeks of Nicotine Patch and Nicotine Gum
Skin RashSkin and subcutaneous tissue disorders63/27550/269
VividDreamsNervous system disorders44/27552/269
NauseaGastrointestinal disorders40/27539/269
InsomniaNervous system disorders29/27531/269
IndigestionGastrointestinal disorders28/27528/269
Itches or HivesSkin and subcutaneous tissue disorders28/27518/269
HeadacheNervous system disorders24/27519/269
DizzinessNervous system disorders23/27519/269
Mouth ProblemsGastrointestinal disorders17/27518/269

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)1, 26Wks, Counseling, CAM, AutoCalls, Feedback2, 26Wks, Counseling, CAM, AutoCalls, No Feedback3, 26Wks, Counseling, CAM, No AutoCalls, Feedback4, 26Wks, Counseling, CAM, No AutoCalls, No Feedback5, 26Wks, Counseling, No CAM, AutoCalls, Feedback6, 26Wks, Counseling, No CAM, AutoCalls, No Feedback7, 26Wks, Counseling, No CAM, No AutoCalls, Feedback8, 26Wks, Counseling, No CAM, No AutoCalls, No Feedback9, 26Wks, No Counseling, CAM, AutoCalls, Feedback10, 26Wks, No Counseling, CAM, AutoCalls, No Feedback11, 26Wks, No Counseling, CAM, No AutoCalls, Feedback12, 26Wks, No Counseling, CAM, No AutoCalls, No Feedback13, 26Wks, No Counseling, No CAM, AutoCalls, Feedback14, 26Wks, No Counseling, No CAM, AutoCalls, No Feedback15, 26Wks, No Counseling, No CAM, No AutoCalls, Feedback16, 26Wks, No Counseling, No CAM, No AutoCalls, No Feedback17, 8Wks, Counseling, CAM, AutoCalls, Feedback18, 8Wks, Counseling, CAM, AutoCalls, No Feedback19, 8Wks, Counseling, CAM, No AutoCalls, Feedback20, 8Wks, Counseling, CAM, No AutoCalls, No Feedback21, 8Wks, Counseling, No CAM, AutoCalls, Feedback22, 8Wks, Counseling, No CAM, AutoCalls, No Feedback23, 8Wks, Counseling, No CAM, No AutoCalls, Feedback24, 8Wks, Counseling, No CAM, No AutoCalls, No Feedback25, 8Wks, No Counseling, CAM, AutoCalls, Feedback26, 8Wks, No Counseling, CAM, AutoCalls, No Feedback27, 8Wks, No Counseling, CAM, No AutoCalls, Feedback28, 8Wks, No Counseling, CAM, No AutoCalls, No Feedback29, 8Wks, No Counseling, No CAM, AutoCalls, Feedback30, 8Wks, No Counseling, No CAM, AutoCalls, No Feedback31, 8Wks, No Counseling, No CAM, No AutoCalls, Feedback32, 8Wks, No Counseling, No CAM, No AutoCalls, No FeedbackTotal
<=18 years000000000000000010000000001000002
Between 18 and 65 years1216131615181415181917151718141510151616151216161714161719141216493
>=65 years1113111041010143311224501011012249
Age, Continuous
Age, Continuous(years)1, 26Wks, Counseling, CAM, AutoCalls, Feedback2, 26Wks, Counseling, CAM, AutoCalls, No Feedback3, 26Wks, Counseling, CAM, No AutoCalls, Feedback4, 26Wks, Counseling, CAM, No AutoCalls, No Feedback5, 26Wks, Counseling, No CAM, AutoCalls, Feedback6, 26Wks, Counseling, No CAM, AutoCalls, No Feedback7, 26Wks, Counseling, No CAM, No AutoCalls, Feedback8, 26Wks, Counseling, No CAM, No AutoCalls, No Feedback9, 26Wks, No Counseling, CAM, AutoCalls, Feedback10, 26Wks, No Counseling, CAM, AutoCalls, No Feedback11, 26Wks, No Counseling, CAM, No AutoCalls, Feedback12, 26Wks, No Counseling, CAM, No AutoCalls, No Feedback13, 26Wks, No Counseling, No CAM, AutoCalls, Feedback14, 26Wks, No Counseling, No CAM, AutoCalls, No Feedback15, 26Wks, No Counseling, No CAM, No AutoCalls, Feedback16, 26Wks, No Counseling, No CAM, No AutoCalls, No Feedback17, 8Wks, Counseling, CAM, AutoCalls, Feedback18, 8Wks, Counseling, CAM, AutoCalls, No Feedback19, 8Wks, Counseling, CAM, No AutoCalls, Feedback20, 8Wks, Counseling, CAM, No AutoCalls, No Feedback21, 8Wks, Counseling, No CAM, AutoCalls, Feedback22, 8Wks, Counseling, No CAM, AutoCalls, No Feedback23, 8Wks, Counseling, No CAM, No AutoCalls, Feedback24, 8Wks, Counseling, No CAM, No AutoCalls, No Feedback25, 8Wks, No Counseling, CAM, AutoCalls, Feedback26, 8Wks, No Counseling, CAM, AutoCalls, No Feedback27, 8Wks, No Counseling, CAM, No AutoCalls, Feedback28, 8Wks, No Counseling, CAM, No AutoCalls, No Feedback29, 8Wks, No Counseling, No CAM, AutoCalls, Feedback30, 8Wks, No Counseling, No CAM, AutoCalls, No Feedback31, 8Wks, No Counseling, No CAM, No AutoCalls, Feedback32, 8Wks, No Counseling, No CAM, No AutoCalls, No FeedbackTotal
Mean45.08 ± 12.3743.82 ± 9.8739.86 ± 10.5449.42 ± 14.2548.81 ± 14.6148.89 ± 9.7247.33 ± 9.8343.53 ± 8.3251.55 ± 13.5146.50 ± 11.0444.29 ± 10.7146.69 ± 11.4446.41 ± 9.5644.58 ± 13.6849.33 ± 17.4950.39 ± 12.5649.07 ± 16.2847.00 ± 13.1142.53 ± 12.8645.72 ± 12.9147.35 ± 12.8051.81 ± 13.9748.76 ± 14.4539.19 ± 11.6445.50 ± 12.7141.50 ± 10.7142.67 ± 14.2045.72 ± 10.6039.53 ± 12.2545.33 ± 12.6947.21 ± 16.6146.78 ± 13.1246.12 ± 12.76
Sex: Female, Male
Sex: Female, Male(Participants)1, 26Wks, Counseling, CAM, AutoCalls, Feedback2, 26Wks, Counseling, CAM, AutoCalls, No Feedback3, 26Wks, Counseling, CAM, No AutoCalls, Feedback4, 26Wks, Counseling, CAM, No AutoCalls, No Feedback5, 26Wks, Counseling, No CAM, AutoCalls, Feedback6, 26Wks, Counseling, No CAM, AutoCalls, No Feedback7, 26Wks, Counseling, No CAM, No AutoCalls, Feedback8, 26Wks, Counseling, No CAM, No AutoCalls, No Feedback9, 26Wks, No Counseling, CAM, AutoCalls, Feedback10, 26Wks, No Counseling, CAM, AutoCalls, No Feedback11, 26Wks, No Counseling, CAM, No AutoCalls, Feedback12, 26Wks, No Counseling, CAM, No AutoCalls, No Feedback13, 26Wks, No Counseling, No CAM, AutoCalls, Feedback14, 26Wks, No Counseling, No CAM, AutoCalls, No Feedback15, 26Wks, No Counseling, No CAM, No AutoCalls, Feedback16, 26Wks, No Counseling, No CAM, No AutoCalls, No Feedback17, 8Wks, Counseling, CAM, AutoCalls, Feedback18, 8Wks, Counseling, CAM, AutoCalls, No Feedback19, 8Wks, Counseling, CAM, No AutoCalls, Feedback20, 8Wks, Counseling, CAM, No AutoCalls, No Feedback21, 8Wks, Counseling, No CAM, AutoCalls, Feedback22, 8Wks, Counseling, No CAM, AutoCalls, No Feedback23, 8Wks, Counseling, No CAM, No AutoCalls, Feedback24, 8Wks, Counseling, No CAM, No AutoCalls, No Feedback25, 8Wks, No Counseling, CAM, AutoCalls, Feedback26, 8Wks, No Counseling, CAM, AutoCalls, No Feedback27, 8Wks, No Counseling, CAM, No AutoCalls, Feedback28, 8Wks, No Counseling, CAM, No AutoCalls, No Feedback29, 8Wks, No Counseling, No CAM, AutoCalls, Feedback30, 8Wks, No Counseling, No CAM, AutoCalls, No Feedback31, 8Wks, No Counseling, No CAM, No AutoCalls, Feedback32, 8Wks, No Counseling, No CAM, No AutoCalls, No FeedbackTotal
Female610812111399121191111101010891010111012101181010129811321
Male776756661098569886778669676887667223
Region of Enrollment
Region of Enrollment(participants)1, 26Wks, Counseling, CAM, AutoCalls, Feedback2, 26Wks, Counseling, CAM, AutoCalls, No Feedback3, 26Wks, Counseling, CAM, No AutoCalls, Feedback4, 26Wks, Counseling, CAM, No AutoCalls, No Feedback5, 26Wks, Counseling, No CAM, AutoCalls, Feedback6, 26Wks, Counseling, No CAM, AutoCalls, No Feedback7, 26Wks, Counseling, No CAM, No AutoCalls, Feedback8, 26Wks, Counseling, No CAM, No AutoCalls, No Feedback9, 26Wks, No Counseling, CAM, AutoCalls, Feedback10, 26Wks, No Counseling, CAM, AutoCalls, No Feedback11, 26Wks, No Counseling, CAM, No AutoCalls, Feedback12, 26Wks, No Counseling, CAM, No AutoCalls, No Feedback13, 26Wks, No Counseling, No CAM, AutoCalls, Feedback14, 26Wks, No Counseling, No CAM, AutoCalls, No Feedback15, 26Wks, No Counseling, No CAM, No AutoCalls, Feedback16, 26Wks, No Counseling, No CAM, No AutoCalls, No Feedback17, 8Wks, Counseling, CAM, AutoCalls, Feedback18, 8Wks, Counseling, CAM, AutoCalls, No Feedback19, 8Wks, Counseling, CAM, No AutoCalls, Feedback20, 8Wks, Counseling, CAM, No AutoCalls, No Feedback21, 8Wks, Counseling, No CAM, AutoCalls, Feedback22, 8Wks, Counseling, No CAM, AutoCalls, No Feedback23, 8Wks, Counseling, No CAM, No AutoCalls, Feedback24, 8Wks, Counseling, No CAM, No AutoCalls, No Feedback25, 8Wks, No Counseling, CAM, AutoCalls, Feedback26, 8Wks, No Counseling, CAM, AutoCalls, No Feedback27, 8Wks, No Counseling, CAM, No AutoCalls, Feedback28, 8Wks, No Counseling, CAM, No AutoCalls, No Feedback29, 8Wks, No Counseling, No CAM, AutoCalls, Feedback30, 8Wks, No Counseling, No CAM, AutoCalls, No Feedback31, 8Wks, No Counseling, No CAM, No AutoCalls, Feedback32, 8Wks, No Counseling, No CAM, No AutoCalls, No FeedbackTotal
United States1317141916191515222017161719181814161718171621161814181819151418544
08

Study locations

1 site
  • University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
    Madison, Wisconsin 53711, United States
09

References and documents

Publications

  • McCarthy DE, Piasecki TM, Lawrence DL, Jorenby DE, Shiffman S, Baker TB. Psychological mediators of bupropion sustained-release treatment for smoking cessation. Addiction. 2008 Sep;103(9):1521-33. doi: 10.1111/j.1360-0443.2008.02275.x. PubMed 18783504 ↗
  • Schlam TR, Baker TB, Smith SS, Bolt DM, McCarthy DE, Cook JW, Hayes-Birchler T, Fiore MC, Piper ME. Electronically Monitored Nicotine Gum Use Before and After Smoking Lapses: Relationship With Lapse and Relapse. Nicotine Tob Res. 2020 Oct 29;22(11):2051-2058. doi: 10.1093/ntr/ntaa116. PubMed 32598468 ↗
  • Schlam TR, Cook JW, Baker TB, Hayes-Birchler T, Bolt DM, Smith SS, Fiore MC, Piper ME. Can we increase smokers' adherence to nicotine replacement therapy and does this help them quit? Psychopharmacology (Berl). 2018 Jul;235(7):2065-2075. doi: 10.1007/s00213-018-4903-y. Epub 2018 Apr 25. PubMed 29696311 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01120704
Lead sponsor
University of Wisconsin, Madison
Collaborators
Dean Health System, Mercy Health System, Wake Forest University Health Sciences, National Cancer Institute (NCI)
Responsible party
Sponsor
First posted
May 11, 2010
Start date
Jun 2010
Primary completion
May 2014
Completion
May 2014
Results posted
Feb 16, 2015
Last update
Dec 11, 2015

Study contacts

Michael C Fiore, MD, MPH, MBA
principal investigator · University of Wisconsin School of Medicine and Public Health, Center for Tobacco Research and Intervention
Tanya R Schlam, PhD
study director · University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion